ID

38775

Descripción

A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM); ODM derived from: https://clinicaltrials.gov/show/NCT01733758

Link

https://clinicaltrials.gov/show/NCT01733758

Palabras clave

Versiones (1)
  1. 3/11/19 3/11/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

3 de noviembre de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes Mellitus, Type 2 NCT01733758

Inglés

Eligibility Diabetes Mellitus, Type 2 NCT01733758

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
subjects with diagnosis of type 2 diabetes mellitus, treated with diet and exercise or a stable dose of 1 oad at screening
Descripción

Diabetes Mellitus, Non-Insulin-Dependent | Diet therapy | Exercise | Antidiabetics Oral Quantity | Antidiabetics Dose Stable

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0012159
UMLS CUI [3]
C0015259
UMLS CUI [4,1]
C0935929
UMLS CUI [4,2]
C1527415
UMLS CUI [4,3]
C1265611
UMLS CUI [5,1]
C0935929
UMLS CUI [5,2]
C0178602
UMLS CUI [5,3]
C0205360
body mass index (bmi) 17 to 40 kg/ m^2 inclusive
Descripción

Body mass index

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
subjects who are oad naïve, hba1c between 7.0% and 10.0% at screening and at visit 2; for subjects who enter the study with 1 oad, hba1c between 6.5% and 9.5% at screening and hba1c between 7.0% and 10.0% at visit 2
Descripción

Antidiabetics Oral Absent | Hemoglobin A1c measurement | Antidiabetics Oral Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C0332197
UMLS CUI [2]
C0474680
UMLS CUI [3,1]
C0935929
UMLS CUI [3,2]
C1527415
UMLS CUI [3,3]
C1265611
creatinine clearance >30 ml/min (calculated using the cockcroft-gault formula)
Descripción

Estimation of creatinine clearance by Cockcroft-Gault formula

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2711451
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of type 1 diabetes mellitus •female subject is pregnant, lactating, or <6 weeks postpartum•
Descripción

Diabetes Mellitus, Insulin-Dependent | Pregnancy | Breast Feeding | Postpartum Period

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011854
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0006147
UMLS CUI [4]
C0086839
clinically significant cardiovascular and/or cerebrovascular disease
Descripción

Cardiovascular Disease | Cerebrovascular Disorder

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0007820
current ongoing symptomatic biliary disease, clinical signs or symptoms of pancreatitis, or a history of chronic or acute pancreatitis, as determined by the investigator
Descripción

Gall Bladder Disease Symptomatic | Sign or Symptom Pancreatitis | Pancreatitis, Chronic | Pancreatitis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0016977
UMLS CUI [1,2]
C0231220
UMLS CUI [2,1]
C3540840
UMLS CUI [2,2]
C0030305
UMLS CUI [3]
C0149521
UMLS CUI [4]
C0030305
serum amylase >=3 ×uln and/or serum lipase >=2 × uln and/or subject is experiencing any symptoms possibly related to pancreatitis
Descripción

Serum amylase raised | Serum lipase raised | Symptoms Relationship Pancreatitis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0476327
UMLS CUI [2]
C3670924
UMLS CUI [3,1]
C1457887
UMLS CUI [3,2]
C0439849
UMLS CUI [3,3]
C0030305
prior use of a tzd or glp-1r agonist within 4 months before screening
Descripción

Thiazolidinediones | GLP-1R Agonist

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1257987
UMLS CUI [2,1]
C0378073
UMLS CUI [2,2]
C2987634
Volver a la parte superior de la página

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT01733758

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent | Diet therapy | Exercise | Antidiabetics Oral Quantity | Antidiabetics Dose Stable
Item
subjects with diagnosis of type 2 diabetes mellitus, treated with diet and exercise or a stable dose of 1 oad at screening
boolean
C0011860 (UMLS CUI [1])
C0012159 (UMLS CUI [2])
C0015259 (UMLS CUI [3])
C0935929 (UMLS CUI [4,1])
C1527415 (UMLS CUI [4,2])
C1265611 (UMLS CUI [4,3])
C0935929 (UMLS CUI [5,1])
C0178602 (UMLS CUI [5,2])
C0205360 (UMLS CUI [5,3])
Body mass index
Item
body mass index (bmi) 17 to 40 kg/ m^2 inclusive
boolean
C1305855 (UMLS CUI [1])
Antidiabetics Oral Absent | Hemoglobin A1c measurement | Antidiabetics Oral Quantity
Item
subjects who are oad naïve, hba1c between 7.0% and 10.0% at screening and at visit 2; for subjects who enter the study with 1 oad, hba1c between 6.5% and 9.5% at screening and hba1c between 7.0% and 10.0% at visit 2
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0474680 (UMLS CUI [2])
C0935929 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
Estimation of creatinine clearance by Cockcroft-Gault formula
Item
creatinine clearance >30 ml/min (calculated using the cockcroft-gault formula)
boolean
C2711451 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent | Pregnancy | Breast Feeding | Postpartum Period
Item
history of type 1 diabetes mellitus •female subject is pregnant, lactating, or <6 weeks postpartum•
boolean
C0011854 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0086839 (UMLS CUI [4])
Cardiovascular Disease | Cerebrovascular Disorder
Item
clinically significant cardiovascular and/or cerebrovascular disease
boolean
C0007222 (UMLS CUI [1])
C0007820 (UMLS CUI [2])
Gall Bladder Disease Symptomatic | Sign or Symptom Pancreatitis | Pancreatitis, Chronic | Pancreatitis
Item
current ongoing symptomatic biliary disease, clinical signs or symptoms of pancreatitis, or a history of chronic or acute pancreatitis, as determined by the investigator
boolean
C0016977 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C3540840 (UMLS CUI [2,1])
C0030305 (UMLS CUI [2,2])
C0149521 (UMLS CUI [3])
C0030305 (UMLS CUI [4])
Serum amylase raised | Serum lipase raised | Symptoms Relationship Pancreatitis
Item
serum amylase >=3 ×uln and/or serum lipase >=2 × uln and/or subject is experiencing any symptoms possibly related to pancreatitis
boolean
C0476327 (UMLS CUI [1])
C3670924 (UMLS CUI [2])
C1457887 (UMLS CUI [3,1])
C0439849 (UMLS CUI [3,2])
C0030305 (UMLS CUI [3,3])
Thiazolidinediones | GLP-1R Agonist
Item
prior use of a tzd or glp-1r agonist within 4 months before screening
boolean
C1257987 (UMLS CUI [1])
C0378073 (UMLS CUI [2,1])
C2987634 (UMLS CUI [2,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial